Adiponectin: Mechanistic insights and clinical implications

Research output: Contribution to journalArticle

340 Citations (Scopus)

Abstract

Adiponectin is an adipocyte-derived secretory protein that has been very widely studied over the past 15 years. A multitude of different functions have been attributed to this adipokine. It has been characterised in vitro at the level of tissue culture systems and in vivo through genetic manipulation of rodent models. It is also widely accepted as a biomarker in clinical studies. Originating in adipose tissue, generally positive metabolic effects have been attributed to adiponectin. In this review, we briefly discuss the key characteristics of this interesting but very complex molecule, highlight recent results in the context of its mechanism of action and summarise some of the key epidemiological data that helped establish adiponectin as a robust biomarker for insulin sensitivity, cardiovascular disease and many additional disease phenomena.

Original languageEnglish (US)
Pages (from-to)2319-2326
Number of pages8
JournalDiabetologia
Volume55
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Adiponectin
Biomarkers
Adipokines
Adipocytes
Insulin Resistance
Adipose Tissue
Rodentia
Cardiovascular Diseases
Proteins

Keywords

  • Adipokines
  • Adiponectin
  • Ceramides
  • Diabetes mellitus
  • Insulin-sensitivity
  • Obesity
  • Review

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Adiponectin : Mechanistic insights and clinical implications. / Turer, A. T.; Scherer, P. E.

In: Diabetologia, Vol. 55, No. 9, 09.2012, p. 2319-2326.

Research output: Contribution to journalArticle

@article{1e8d25f82bd1430c9b0cb8519b93d19b,
title = "Adiponectin: Mechanistic insights and clinical implications",
abstract = "Adiponectin is an adipocyte-derived secretory protein that has been very widely studied over the past 15 years. A multitude of different functions have been attributed to this adipokine. It has been characterised in vitro at the level of tissue culture systems and in vivo through genetic manipulation of rodent models. It is also widely accepted as a biomarker in clinical studies. Originating in adipose tissue, generally positive metabolic effects have been attributed to adiponectin. In this review, we briefly discuss the key characteristics of this interesting but very complex molecule, highlight recent results in the context of its mechanism of action and summarise some of the key epidemiological data that helped establish adiponectin as a robust biomarker for insulin sensitivity, cardiovascular disease and many additional disease phenomena.",
keywords = "Adipokines, Adiponectin, Ceramides, Diabetes mellitus, Insulin-sensitivity, Obesity, Review",
author = "Turer, {A. T.} and Scherer, {P. E.}",
year = "2012",
month = "9",
doi = "10.1007/s00125-012-2598-x",
language = "English (US)",
volume = "55",
pages = "2319--2326",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Adiponectin

T2 - Mechanistic insights and clinical implications

AU - Turer, A. T.

AU - Scherer, P. E.

PY - 2012/9

Y1 - 2012/9

N2 - Adiponectin is an adipocyte-derived secretory protein that has been very widely studied over the past 15 years. A multitude of different functions have been attributed to this adipokine. It has been characterised in vitro at the level of tissue culture systems and in vivo through genetic manipulation of rodent models. It is also widely accepted as a biomarker in clinical studies. Originating in adipose tissue, generally positive metabolic effects have been attributed to adiponectin. In this review, we briefly discuss the key characteristics of this interesting but very complex molecule, highlight recent results in the context of its mechanism of action and summarise some of the key epidemiological data that helped establish adiponectin as a robust biomarker for insulin sensitivity, cardiovascular disease and many additional disease phenomena.

AB - Adiponectin is an adipocyte-derived secretory protein that has been very widely studied over the past 15 years. A multitude of different functions have been attributed to this adipokine. It has been characterised in vitro at the level of tissue culture systems and in vivo through genetic manipulation of rodent models. It is also widely accepted as a biomarker in clinical studies. Originating in adipose tissue, generally positive metabolic effects have been attributed to adiponectin. In this review, we briefly discuss the key characteristics of this interesting but very complex molecule, highlight recent results in the context of its mechanism of action and summarise some of the key epidemiological data that helped establish adiponectin as a robust biomarker for insulin sensitivity, cardiovascular disease and many additional disease phenomena.

KW - Adipokines

KW - Adiponectin

KW - Ceramides

KW - Diabetes mellitus

KW - Insulin-sensitivity

KW - Obesity

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84866133825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866133825&partnerID=8YFLogxK

U2 - 10.1007/s00125-012-2598-x

DO - 10.1007/s00125-012-2598-x

M3 - Article

C2 - 22688349

AN - SCOPUS:84866133825

VL - 55

SP - 2319

EP - 2326

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 9

ER -